Established in 2011, Novoxel Ltd. focuses on scientific and clinical innovation, holding numerous patents worldwide. Their Tixel family of products utilize proprietary Thermo-Mechanical Action (TMA®) to deliver noticeable clinical results. These treatments are non-invasive, radiation-free, require minimal downtime, and require no expensive single-use cartridges, no bleeding, or significant pain.